This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMark Partners, Hillhouse Capital Group, Mirae Asset Financial Group, Syno Capital, Haitong International Securities, Lucion Group, Sirona Capital, Alexandria Venture Investments, and affiliates of Leerink Partners. Existing investors MPM Capital, F2 Ventures, and Cathay Fortune Capital Investment also participated.
Gene Therapy, Cell Therapy
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?